Browse > Article

Systematic Approach for the Diagnosis of IEM in the Neonatal Period  

Lee, Hong Jin (Department of Pediatrics, Hallym University)
Publication Information
Journal of The Korean Society of Inherited Metabolic disease / v.14, no.1, 2014 , pp. 10-18 More about this Journal
Abstract
Recent advances in the diagnosis and treatment of inborn errors of metabolism have improved substantially the prognosis of many of these diseases, if diagnosed early enough before irreversible damage occurs. This makes it essential that the practicing pediatrician, especially neonatologists be familliar with the clinical presentations and systematic approaches of these disorders. Characteristic clinical presentations, methods of systematic approach and typing of various disorders is discussed in this review. The signs of neurological dysfunctions of many IEMs manifesting in the neonatal period is very nonspecific, such as poor feeding, poor sucking, apnea or tachypnea, vomiting, hypertonia, hypotonia, seizure, letharginess, consciousness change and coma. Many other non-metabolic severe disorders of neonatal period such as neonatal sepsis and intracerebral hemorrhage share these nonspecific symptoms. Hyperammonemia, metabolic acidosis, ketosis and hyperlatic acidemia are observed in many of these conditions but there are exceptions in which conditions all basal laboratory tests are normal, such as NKH, sulfite oxidase deficiency and peroxisomal disorders. According to the results of basal laboratory tests, IEMs in the neonatal period can be categorized in to 6 types. Grouping of IEMs into 6 types will make confirmatory tests and early emergency treatment more efficient.
Keywords
IEM; Neonate; Nonspecific; Systematic approach; Hyperammonemia; Metabolic acidosis; Hyperlactic acidemia;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Saudubray JM, Desguerre I, Sedel F, Charpentier C: A clinical approach to inherited metabolic disorders. In Fernandes J, Saudubray JM, van den Berghe G, Walter J, eds. Inborn metabolic Diseases:Diagnosis and Treatment, 4th edn. Berlin: Springer-Verlag, 2006.
2 Burton BK. Nadler HL. Clinical diagnosis of inborn errors of metabolism in the neonatal period. Pediatrics 1978;61:398-405.   DOI
3 Goodman SI. Inherited metabolic disease in the newborn: approach to diagnosis and treatment. Enzyme 1987;38:76-9.
4 Tada K, Kure S. Non-ketotic hyperglycinaemia: molecular lesion, diagnosis and pathophysiology. J Inherit Metab Dis 1993;16:691-703.   DOI
5 Chalmers PT, Lawson AH. Organic acids in man, Chapman and hall, 1982, Vol I.
6 Di mauro S, Bonilla E, Zeviani M, Servidei S, De Vivo DC, Schon EA. Mitochondrial myopathies. J Inherit Metab Dis 1987;10(suppl 1):113-28.   DOI
7 Braverman NE1, D'Agostino MD, Maclean GE. Peroxisome biogenesis disorders: Biological, clinical and pathophysiological perspectives. Dev Disabil Res Rev 2013;17:187-96.   DOI   ScienceOn
8 Renaud DL. Leukoencephalopathies associated with macrocephaly. Semin Neurol 2012;32:34-41.   DOI   ScienceOn
9 Oliveira AR, Valente R, Ramos J, Ventura L. Persistent hyperlactacidaemia: about a clinical case. BMJ Case Rep 2013;22:2013.
10 Knerr I, Weinhold N, Vockley J, Gibson KM. Advances and challenges in the treatment of branchedchain amino/keto acid metabolic defects. J Inherit Metab Dis 2012;35:29-40.   DOI
11 Mahoney MJ. Organic acidemias. Clin Perinatol 1976;3:61-78.
12 Pena L, Franks J, Chapman KA, Gropman A, Ah Mew N, Chakrapani A, et al. Natural history of propionic acidemia. Mol Genet Metab 2012;105:5-9.   DOI   ScienceOn
13 Hoffmann GF, Kolker S. Defects in amino acid catabolism and the urea cycle. Handb Clin Neurol 2013;113:1755-73.   DOI   ScienceOn
14 Gordon N. Glutaric aciduria types I and II. Brain Dev 2006;28:136-40.   DOI   ScienceOn
15 Lund AM, Skovby F, Vestergaard H, Christensen M, Christensen E. Clinical and biochemical monitoring of patients with fatty acid oxidation disorders. J Inherit Metab Dis 2010;33:495-500.   DOI
16 Fukao T, Mitchell G, Sass JO, Hori T, Orii K, Aoyama Y. Ketone body metabolism and its defects. J Inherit Metab Dis. 2014 Apr 8. [Epub ahead of print]
17 De Meirleir L. Disorders of pyruvate metabolism. Handb Clin Neurol 2013;113:1667-73.   DOI   ScienceOn
18 Rothberg AD, Thomson PD, Andronikou S, Cohen DF. Transient neonatal hyperammonaemia. A case report. S Afr Med J 1982;31;62:175-6.
19 Nyhan WL. Multiple carboxylase deficiency. Int J Biochem 1988;20:363-70.   DOI   ScienceOn
20 Hoffmann GF, Kolker S. Defects in amino acid catabolism and the urea cycle. Handb Clin Neurol 2013;113:1755-73.   DOI   ScienceOn
21 Tan WH, Eichler FS, Hoda S, Lee MS, Baris H, Hanley CA, et al. Isolated sulfite oxidase deficiency: a case report with a novel mutation and review of the literature. Pediatrics 2005;116:757-66.   DOI   ScienceOn
22 Hommes FA. Inborn errors of fructose metabolism. Am J Clin Nutr 1993;58(5 Suppl):788S-95S.
23 Kitagawa T. Hepatorenal tyrosinemia. Proc Jpn Acad Ser B Phys Biol Sci 2012;88:192-200.   DOI
24 Devictor D, Tissieres P, Afanetti M, Debray D. Acute liver failure in children. Clin Res Hepatol Gastroenterol 2011;35:430-7.   DOI   ScienceOn